Table 3.
Author Reference | Country | Study Design | Participants | Changes in the Composition of Gut Microbiota in HCC | Key Findings |
---|---|---|---|---|---|
Human Studies | |||||
[79] | Poland | Cross-sectional | 15 HCC 5 without HCC All participants had cirrhosis and underwent liver transplantation. |
↑ Escherichia coli
↑ Enterobacteriaceae ↑ Enterococcus ↑ Lactobacillus ↑ H2O2-producing Lactobacillus species |
↑ Fecal counts of E coli were noted in the cirrhotic-HCC group, demonstrating its role in HCC development |
[88] | Australia | Cohort study; metagenomics and metabolomics analysis |
32 NAFLD-HCC 28 NAFLD-cirrhosis 30 non-NAFLD controls |
↑ Proteobacteria
↑ Enterobacteriaceae ↑ Bacteroides xylanisolvens ↑ B. caecimuris ↑ Ruminococcus gnavus ↑ Clostridium bolteae ↑ Veillonella parvula ↑ Bacteroides caecimuris ↑ Veillonella parvula ↑ Clostridium bolteae ↑ Ruminococcus gnavus ↓ Oscillospiraceae ↓ Erysipelotrichaceae ↓ Eubacteriaceae |
↑ B. caecimuris and Veillonella parvula distinguished NAFLD-HCC from NAFLD-cirrhosis and non-NAFLD controls ↓ Gut microbial α-diversity ↑ SCFAs serum levels in NAFLD-HCC compared to NAFLD-cirrhosis and non-NAFLD control Gut microbiota in NAFLD-HCC microbiota contribute to immunosuppression |
[89] | China | Cohort | 75 with early HCC 40 liver cirrhosis 75 healthy controls |
↑ Actinobacteria
↑ Gemmiger ↑ Parabacteroides ↑ Paraprevotella ↑ Klebsiella ↑ Haemophilus ↓ Verrucomicrobia ↓ Alistipes ↓ Phascolarctobacterium ↓ Ruminococcus ↓ Oscillibacter ↓ Faecalibacterium ↓ Clostridium IV ↓ Coprococcus |
↓ Butyrate-producing bacteria ↑ LPS-producing bacteria in early HCC versus healthy controls |
[82] | China | Case-control | 57 HCC (35 with HBV related HCC, 22 with non-HBV non-HCV related HCC) 33 healthy controls |
↑ Bifidobacterium
↑ Lactobacillus ↓ Proteobacteria ↓ Firmicutes |
↓ Anti-inflammatory and ↑ pro-inflammatory bacteria in non-HBC non-HCV related HCC patients which correlated with their increased alcohol consumption |
[81] | China | Case-control | 68 with primary HCC: (23 Stage I, 13 Stage II, 30 Stage III, 2 Stage IV) 18 healthy controls |
↑ Dysbiosis index Proteobacteria (Enterobacter, Haemophilus) ↑ Desulfococcus ↑ Prevotella ↑ Veillonella ↓ Cetobacterium |
↑ Dysbiosis index in patients with primary HCC compared with healthy controls |
[83] | Italy | Cohort | 21 with NAFLD-related cirrhosis with HCC 20 NAFLD-related cirrhosis without HCC 20 healthy controls |
↑ Bacteroides
↑ Ruminococcaceae ↓ Bifidobacterium |
↑ Fecal calprotectin in HCC patients, which explains increased inflammation |
[90] | Argentina | Case-control | 407 Cirrhosis: 25 with HCC, 25 w/o HCC 25 healthy controls |
↑ Erysipelotrichaceae
↑ Odoribacter ↑ Butyricimonas ↓ Leuconostocaceae ↓ Fusobacterium ↓ Lachnospiraceae |
↓ Prevotella in cirrhotic patients with HCC, which is associated with the activation of several inflammatory pathways such as the NLR signalling pathways |
[91] | China | Case-control | 24 PLC 24 cirrhosis 23 healthy controls |
↑ Enterobacter ludwigii
↑ Enterococcaceae ↑ Lactobacillales ↑ Bacilli ↑ Gammaproteobacteria ↑ Veillonella ↓ diversity of Firmicutes ↓ Clostridia ↓ Subdoligranulum |
Veillonella positively correlated with AFP Subdoligranulum negatively correlated with AFP Subdoligranulum contains SCFA-producing lineages |
[84] | China | Case-control | 24 hepatitis 24 cirrhosis 75 HCC (35 with HBV, 25 with HCV, 15 with ALD) 20 healthy controls |
↑ Neisseria
↑ Enterobacteriaceae ↑ Veillonella ↑ Limnobacter ↓ Enterococcus ↓ Phyllobacterium ↓ Clostridium ↓ Ruminococcus ↓ Coprococcus |
↑ LPS by harmful bacteria generated liver inflammatory reactions through TLR4 |
Animal experimental model studies | |||||
[78] | Japan | Mice | 24 STZ-HFD (streptozocin-high-fat diet)-induced 24 controls |
↑ Bacteroides
↑ Bacteroides vulgatus ↑ Bacteroides uniformis ↑ Clostridium ↑ Clostridium xylanolyticum ↑ Clostridium fusiformis ↑ Roseburia ↑ Allobaculum sp. id4 ↑ Subdoligranulum ↑ Anaerotruncus ↑ Oscillibacter ↑ Xylanibacter ↑ Mucispirillum schaedleri ↑ Pseudobutyrivibrio ↑ Desulfovibrio ↑ Dehalobacterium ↑ Oscillospira ↑ Sarcina ↑ Atopobium ↑ Peptococcus ↓ Parasutterella ↓ Bacteroides acidofaciens ↓ Odoribacter ↓ Barnesiella ↓ Moryella ↓ Paraprevotella ↓ Lactobacillus intestinalis ↓ Akkermansia |
Clostridium, Bacteroides, and Desulfovibrio were involved in bile acid dysregulation; their increased levels resulted in the preservation of high concentrations of bile acids, further contributing to hepatocarcinogenesis |
AFP, alpha-fetoprotein; ALD, alcohol-associated liver disease; HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma LPS, lipopolysaccharide; NAFLD, nonalcoholic fatty liver disease; PLC, primary liver cancer; SCFAs, short-chain fatty acids; ↑, increase; and ↓, decrease.